Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 1: developing and delivering high-quality independent clinical trials
Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 1: developing and delivering high-quality independent clinical trials
The UK Dermatology Clinical Trials Network (UK DCTN) was formed in 2002 with the aim of developing and supporting high-quality independent national clinical trials that address prioritized research questions for people with skin disease. Its philosophy is to democratize UK dermatological clinical research and to tackle important clinical questions that industry has no incentive to answer. The network also plays a key role in training and capacity development. Its membership of over 1000 individuals includes dermatology consultants, trainees, dermatology nurses, general practitioners, methodologists and patients. Its organizational structures are lean and include a co-ordinating team based at the Centre of Evidence-Based Dermatology in Nottingham, and an executive with independent members to ensure probity and business progression. A prioritization panel and steering group enable a pipeline of projects to be prioritized and refined for external funding from independent sources. The UK DCTN has supported and completed 12 national clinical trials, attracting investment of over £15 million into UK clinical dermatology research. Trials have covered a range of interventions from drugs such as doxycycline (BLISTER), silk clothing for eczema (CLOTHES) and surgical interventions for hidradenitis suppurativa (THESEUS). Trial results are published in prestigious journals and have global impact. Genuine partnership with patients and carers has been a strong feature of the network since its inception. The UK DCTN is proud of its first 20 years of collaborative work, and aims to remain at the forefront of independent dermatological health technology assessment, as well as expanding into areas including diagnostics, artificial intelligence, efficient studies and innovative designs.
Artificial Intelligence, Caregivers, Clinical Trials as Topic, Dermatology, Eczema, Humans, United Kingdom
1048-1059
Williams, Hywel C
3914e691-2348-4704-a044-e8d2af92444e
McPhee, Margaret J
4af3f3e0-6608-4a7e-841d-2f6799a32ffe
Layfield, Carron P
ed9bd4c5-5374-4d1d-9d86-ae473a4b459c
Sach, Tracey
5c09256f-ebed-4d14-853a-181f6c92d6f2
UK Dermatology Clinical Trials Network
June 2022
Williams, Hywel C
3914e691-2348-4704-a044-e8d2af92444e
McPhee, Margaret J
4af3f3e0-6608-4a7e-841d-2f6799a32ffe
Layfield, Carron P
ed9bd4c5-5374-4d1d-9d86-ae473a4b459c
Sach, Tracey
5c09256f-ebed-4d14-853a-181f6c92d6f2
Williams, Hywel C, McPhee, Margaret J, Layfield, Carron P and Sach, Tracey
,
UK Dermatology Clinical Trials Network
(2022)
Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 1: developing and delivering high-quality independent clinical trials.
Clinical and Experimental Dermatology, 47 (6), .
(doi:10.1111/ced.15140).
Abstract
The UK Dermatology Clinical Trials Network (UK DCTN) was formed in 2002 with the aim of developing and supporting high-quality independent national clinical trials that address prioritized research questions for people with skin disease. Its philosophy is to democratize UK dermatological clinical research and to tackle important clinical questions that industry has no incentive to answer. The network also plays a key role in training and capacity development. Its membership of over 1000 individuals includes dermatology consultants, trainees, dermatology nurses, general practitioners, methodologists and patients. Its organizational structures are lean and include a co-ordinating team based at the Centre of Evidence-Based Dermatology in Nottingham, and an executive with independent members to ensure probity and business progression. A prioritization panel and steering group enable a pipeline of projects to be prioritized and refined for external funding from independent sources. The UK DCTN has supported and completed 12 national clinical trials, attracting investment of over £15 million into UK clinical dermatology research. Trials have covered a range of interventions from drugs such as doxycycline (BLISTER), silk clothing for eczema (CLOTHES) and surgical interventions for hidradenitis suppurativa (THESEUS). Trial results are published in prestigious journals and have global impact. Genuine partnership with patients and carers has been a strong feature of the network since its inception. The UK DCTN is proud of its first 20 years of collaborative work, and aims to remain at the forefront of independent dermatological health technology assessment, as well as expanding into areas including diagnostics, artificial intelligence, efficient studies and innovative designs.
Text
Celebrating_20_years_of_UK_Dermatology_Clinical_Trails
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 13 February 2022
Published date: June 2022
Additional Information:
© 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Keywords:
Artificial Intelligence, Caregivers, Clinical Trials as Topic, Dermatology, Eczema, Humans, United Kingdom
Identifiers
Local EPrints ID: 478400
URI: http://eprints.soton.ac.uk/id/eprint/478400
ISSN: 0307-6938
PURE UUID: 129a13bf-8561-414f-a271-88996f229dee
Catalogue record
Date deposited: 29 Jun 2023 16:59
Last modified: 17 Mar 2024 04:19
Export record
Altmetrics
Contributors
Author:
Hywel C Williams
Author:
Margaret J McPhee
Author:
Carron P Layfield
Author:
Tracey Sach
Corporate Author: UK Dermatology Clinical Trials Network
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics